Shares of Progyny Inc (NASDAQ:PGNY) saw unusually-high trading volume on Monday . Approximately 1,230,822 shares were traded during trading, an increase of 88% from the previous session’s volume of 653,173 shares.The stock last traded at $28.54 and had previously closed at $26.64.
A number of research analysts have recently weighed in on PGNY shares. Piper Jaffray Companies assumed coverage on Progyny in a research note on Wednesday, November 27th. They issued an “overweight” rating and a $33.00 price target on the stock. Leerink Swann initiated coverage on shares of Progyny in a report on Wednesday, November 27th. They set an “outperform” rating and a $28.00 target price on the stock. Goldman Sachs Group assumed coverage on shares of Progyny in a research note on Tuesday, November 19th. They issued a “buy” rating and a $33.00 price objective on the stock. Citigroup assumed coverage on shares of Progyny in a report on Wednesday, November 27th. They set a “buy” rating and a $30.00 price target for the company. Finally, Svb Leerink assumed coverage on Progyny in a report on Tuesday, November 19th. They issued an “outperform” rating and a $28.00 price objective for the company. Six analysts have rated the stock with a buy rating, Progyny has an average rating of “Buy” and an average target price of $29.67.
In other news, insider Peter Anevski sold 20,000 shares of Progyny stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $45.20, for a total transaction of $904,000.00. Also, CEO David J. Schlanger sold 960,007 shares of the company’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $16.39, for a total transaction of $15,734,514.73. Over the last ninety days, insiders sold 1,933,004 shares of company stock valued at $32,258,136.
About Progyny (NASDAQ:PGNY)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
See Also: What is the S&P/ASX 200 Index?
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.